Table 3.

Quality Outcomes Among Long-Term Care Residents with Alzheimer’s Disease and Related Dementias.

	(1)	(2)	(3)	(4)	(5)
Residents	Flu Vaccine	Antipsychotic Use	One/More Falls	Physically Restrained	Weight Loss
White	94.07	27.89	8.55	1.20	20.66
	(94.03–94.11)C	(27.82–27.96)A	(8.50–8.60)B	(1.18–1.22)B	(20.60–20.70)B
Black	93.68	21.21	4.61	0.73	19.72
	(93.48–93.88)B	(20.87–21.54)	(4.33–4.90)	(0.65–0.81)A	(19.44–20.00)A
Asian/PI	93.35	22.65	7.54	1.34	20.31
	(92.82–93.87) AB	(21.82–23.47)	(6.75–8.34)A	(1.12–1.55) BC	(19.60–21.03) AB
Hispanic	93.12	27.77	7.94	1.34	19.22
	(92.83–93.41)A	(27.9–28.25)A	(7.49–8.40)A	(1.22–1.55)C	(18.83–19.61)
AI/AN	93.82	26.67	8.32	0.76	21.26
	(92.84–94.79)ABC	(24.78–28.56)A	(6.79–9.95)AB	(0.40–1.13)A	(19.61–22.90) AB
Observations	993,768	949,771	462,561	1,001,543	997,509

Notes: Adjusted rates by race/ethnicitywith confidence intervals in parentheses; models are adjusted by sex, age, dual eligibility, Medicare type (fee-for-service or Medicare Advantage) and included both facility and Zip Code Fixed-effects; standard errors were clustered at the facility level; adjusted rates sharing a letter (e.g., superscripts A, B, and/or C) in the group label are not significantly different at the 5% level; all differences are significant at p<.05.